工程微型CRISPR-Cas Un1Cas12f1用于高效的基础编辑.
Yueer Hu1, Linxiao Han1, Qiqin Mo1
1Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
Molecular therapy. Nucleic acids
|May 20, 2024
概括
新的微型基础编辑器 (STUminiBEs) 克服了基因治疗的腺相关病毒载荷限制. 这些超紧的编辑器实现了A-to-G和C-to-T转换的高效率,从而实现了潜在的生物医学应用.
科学领域:
- 分子生物学分子生物学
- 基因编辑技术的技术
- 生物医学工程 生物医学工程
背景情况:
- 腺相关病毒 (AAV) 是一个有前途的基因疗法载体,但其载荷能力有限 (4.7 kb).
- 现有的SpCas9介导基编辑器超过了AAV包装限制,阻碍了它们的临床使用.
- 开发紧而高效的基准编辑器对于推进体内基因治疗至关重要.
研究的目的:
- 设计适合AAV包装的超紧和高效的基础编辑器.
- 为了提高Un1Cas12f1系统的基础编辑效率.
- 为了在哺乳动物细胞中展示这些微型基编辑器的治疗潜力.
主要方法:
- 工程 Un1Cas12f1 蛋白质和截断单导 RNA (sgRNA) 来创建微型基编辑器 (STUminiBEs).
- 融合非特异性DNA结合蛋白Sso7d以增强编辑器活动.
- 将STUminiBEs包装成AAV载体,以便在哺乳动物细胞中进行输送和测试.
主要成果:
- 使用STUminiABEs实现了强大的A-to-G基础编辑 (54%的平均效率).
- 使用STUminiCBEs证明了高效的C-to-T基础编辑 (45%的平均效率).
- 在哺乳动物细胞中使用AAV包装的STUminiCBEs在PCSK9基因中成功引入过早停止编码.
结论:
- STUminiBEs代表了微型基础编辑器技术的重大进步.
- 这些编辑器被有效地包装成AAV,克服了以前的尺寸限制.
- 对于未来的生物研究和基因治疗中的生物医学应用,STUminiBEs具有很大的前景.
相关概念视频
CRISPR
50.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.6K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K


